AABB hosts biannual meetings that bring together representatives from the blood community with FDA and other relevant federal government agencies to exchange information on topics of mutual concern. Click on a meeting date below for summaries, attendance lists and other resources.
FDA Liaison Meeting - 5/16/19
FDA Liaison Meeting - 3/6/18
FDA Liaison Meeting - 1/31/17
FDA Liaison Meeting - 5/9/16
FDA Liaison Meeting - 9/21/15
FDA Liaison Meeting - 2/27/15
FDA Liaison Meeting - 5/16/14
FDA Liaison Meeting - 9/27/13
FDA Liaison Meeting - 5/2/13
FDA Liaison Meeting - 11/1/12
FDA Liaison Meeting - 4/12/12
FDA Liaison Meeting - 9/30/11
FDA Liaison Meeting - 3/30/11
FDA Liaison Meeting - 11/23/10
FDA Liaison Meeting - 1/7/10
FDA Workshop to Focus on Generating Scientific Evidence to Facilitate CT Development
December 18, 2024
AABB and ARC Submit Comments to Support Manufacture of Platelets by Buffy Coat Method
December 18, 2024
REGULATORY UPDATE: Upcoming Webinar to Focus on FDA Review of BLAs for Blood and Source Plasma
December 11, 2024